Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus is considered to be an extracellular pathogen. However, survival of S. aureus within host cells may provide a reservoir relatively protected from antibiotics, thus enabling long-term colonization of the host and explaining clinical failures and relapses after antibiotic therapy. Here we confirm that intracellular reservoirs of S. aureus in mice comprise a virulent subset of bacteria that can establish infection even in the presence of vancomycin, and we introduce a novel therapeutic that effectively kills intracellular S. aureus. This antibody-antibiotic conjugate consists of an anti-S. aureus antibody conjugated to a highly efficacious antibiotic that is activated only after it is released in the proteolytic environment of the phagolysosome. The antibody-antibiotic conjugate is superior to vancomycin for treatment of bacteraemia and provides direct evidence that intracellular S. aureus represents an important component of invasive infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the Ab-rifalogue complex was more effective than uncoupled antibiotics in combating infection in an in vivo mouse model.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [126]
In the citing paper
“intracellular MRSA represent an important pathogen reservoir that is shielded from antibiotic action.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [126]
In the citing paper
“Mice challenged with infected cells rather than bacterial particles, were shown to present higher bacterial burdens despite vancomycin treatment [126].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [126]
In the citing paper
“rifalogue was conjugated to an S. aureus-specific antibody via a cleavable bridge so that opsonized MRSA, once phagocytosed, could be effectively killed by the protease-liberated antibiotic.”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [126]
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Lewis, K. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134306 · Cited by 1,858
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Diekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362
Activated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J. N., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 672
Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K., Knipe, J. O., Lasch, S. J., & Trail, P. A. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025536j · Cited by 555
Monk, I. R., Shah, I. M., Xu, M., Tan, M.-W., & Foster, T. J. (2012) · mBio · doi:10.1128/mbio.00277-11 · Cited by 542
Kullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463
Survival of Staphylococcus aureus Inside Neutrophils Contributes to Infection
Gresham, H. D., Lowrance, J. H., Caver, T. E., Wilson, B. S., Cheung, A. L., & Lindberg, F. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3713 · Cited by 408
Intracellular staphylococcus aureus: Live-in and let die
Fraunholz, M., & Sinha, B. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00043 · Cited by 377
Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?
Thwaites, G. E., & Gant, V. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2508 · Cited by 320
Que, Y.-A., Haefliger, J.-A., Piroth, L., François, P., Widmer, E., Entenza, J. M., Sinha, B., Herrmann, M., Francioli, P., Vaudaux, P., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050125 · Cited by 286
Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals
Grant, S. S., Kaufmann, B. B., Chand, N. S., Haseley, N., & Hung, D. T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203735109 · Cited by 273
Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M.-P., Tulkens, P. M., & Van Bambeke, F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.841-851.2006 · Cited by 266
Clement, S., Vaudaux, P., Francois, P., Schrenzel, J., Huggler, E., Kampf, S., Chaponnier, C., Lew, D., & Lacroix, J. (2005) · The Journal of Infectious Diseases · doi:10.1086/432735 · Cited by 245
THE SURVIVAL OF STAPHYLOCOCCI WITHIN HUMAN LEUKOCYTES
Rogers, D. E., & Tompsett, R. (1952) · Journal of Experimental Medicine · doi:10.1084/jem.95.2.209 · Cited by 201
Greenlee-Wacker, M. C., Rigby, K. M., Kobayashi, S. D., Porter, A. R., DeLeo, F. R., & Nauseef, W. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302692 · Cited by 182
Nannini, E., Murray, B. E., & Arias, C. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.006 · Cited by 171
Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes
Vaudaux, P., & Waldvogel, F. A. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.6.743 · Cited by 167
Rapid Neutrophil Destruction following Phagocytosis of Staphylococcus aureus
Kobayashi, S. D., Braughton, K. R., Palazzolo-Ballance, A. M., Kennedy, A. D., Sampaio, E., Kristosturyan, E., Whitney, A. R., Sturdevant, D. E., Dorward, D. W., Holland, S. M., et al. (2010) · Journal of Innate Immunity · doi:10.1159/000317134 · Cited by 155
Kaiser, P., Regoes, R. R., Dolowschiak, T., Wotzka, S. Y., Lengefeld, J., Slack, E., Grant, A. J., Ackermann, M., & Hardt, W.-D. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001793 · Cited by 144
Meijer, P., Andersen, P. S., Hansen, M. H., Steinaa, L., Jensen, A. D., Lantto, J., Oleksiewicz, M. B., Tengbjerg, K., Poulsen, T. R., Coljee, V. W., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.02.040 · Cited by 127
Rogers, D. E. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.6.713 · Cited by 107
Garzoni, C., & Kelley, W. L. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100123 · Cited by 103
Yoon, Y. K., Kim, J. Y., Park, D. W., Sohn, J. W., & Kim, M. J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq050 · Cited by 93
Velasco, E., Byington, R., Martins, C. A. S., Schirmer, M. R., Dias, L. M. C., & Gonçalves, V. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0077-8 · Cited by 92
Pathways and roles of wall teichoic acid glycosylation in Staphylococcus aureus
Winstel, V., Xia, G., & Peschel, A. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.10.009 · Cited by 91
Jarry, T. M., Memmi, G., & Cheung, A. L. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01166.x · Cited by 86
Bosse, M. J., Gruber, H. E., & Ramp, W. K. (2005) · JBJS Case Connector · doi:10.2106/jbjs.d.02649 · Cited by 84
Intracellular Activity of Antibiotics against Staphylococcus aureus in a Mouse Peritonitis Model
Sandberg, A., Hessler, J. H. R., Skov, R. L., Blom, J., & Møller, J. K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01605-07 · Cited by 84
INTRACELLULAR SURVIVAL OF STAPHYLOCOCCI
Kapral, F. A., & Shayegani, M. G. (1959) · The Journal of Experimental Medicine · doi:10.1084/jem.110.1.123 · Cited by 83
Johnson, L. B., Almoujahed, M. O., Ilg, K., Maolood, L., & Khatib, R. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016682 · Cited by 81
Noninherited Resistance to Antibiotics
Levin, B. R. (2004) · Science · doi:10.1126/science.1103077 · Cited by 79
Hazenbos, W. L. W., Kajihara, K. K., VANDLEN, R. L., Morisaki, J. H., Lehar, S. M., Kwakkenbos, M. J., Beaumont, T., Bakker, A. Q., Phung, Q. T., Swem, L. R., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003653 · Cited by 77
BOSSE, M. J., GRUBER, H. E., & RAMP, W. K. (2005) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200506000-00022 · Cited by 73
Venditti, M., Falcone, M., Micozzi, A., Carfagna, P., Taglietti, F., Serra, P., & Martino, P. (2003) · PubMed · Cited by 67
The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes
Anwar, S., Prince, L. R., Foster, S. J., Whyte, M. K. B., & Sabroe, I. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03950.x · Cited by 64
Anti-MRSA agents: under investigation, in the exploratory phase and clinically available
Bryskier, A. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.4.505 · Cited by 31
Nielsen, S. L. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.407 · Cited by 17
Meijer, P., Nielsen, L. S., Lantto, J., & Jensen, A. D. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-554-1_13 · Cited by 17
A Doubly Labeled Penetratin Analogue as a Ratiometric Sensor for Intracellular Proteolytic Stability
Fischer, R., Hufnagel, H., & Brock, R. E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900301k · Cited by 14
Boullanger, P., Descotes, G., Flandrois, J., & Marmet, D. (1982) · Carbohydrate Research · doi:10.1016/0008-6215(82)85034-9 · Cited by 10
Cited by
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370
Strategies and challenges for the next generation of antibody–drug conjugates
Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
“Such a scenario was recently illustrated by Lehar and colleagues, who showed that, compared to extracellular planktonic bacteria, intracellular MRSA isolates exhibit a 100-fold increase in the vancomycin MIC, as well as an enhanced propensity for systemic dissemination in an antibiotic-treated mouse infection model (2…”
BackgroundMethicillin-resistant Staphylococcus aureus
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,556
Persistent bacterial infections and persister cells
Fisher, R. A., Gollan, B., & Helaine, S. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.42 · Cited by 1,243
Metadata
- Authors
- Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., Kim, J., Park, S., Darwish, M., Lee, B.-C., Hernandez, H., Loyet, K. M., Lupardus, P., Fong, R., Yan, D., Chalouni, C., Luis, E., Khalfin, Y., Plise, E., Cheong, J., Lyssikatos, J. P., Strandh, M., Koefoed, K., Andersen, P. S., Flygare, J. A., Wah Tan, M., Brown, E. J., & Mariathasan, S.
- Affiliations
- Genentech (US)
- Symphogen (Denmark) (DK)
- Corresponding author
- Brown, Eric J.
- Mariathasan, Sanjeev
- ORCID
- Venue
- Nature
- Published
- 2015-11
- Volume
- 527
- Issue
- 7578
- Pages
- 323-328
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1915856409
- Cited by
- 838
- References
- 45
- Citations by year
- 2026: 53 · 2025: 80 · 2024: 72 · 2023: 89 · 2022: 88 · 2021: 79 · 2020: 86 · 2019: 92 · 2018: 85 · 2017: 64 · 2016: 43 · 2015: 5
- FWCI
- 51.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Keywords
- Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, antibiotic resistance, bacteremia, phagolysosomes, wall teichoic acid, vancomycin, host cell internalization, antibiotic delivery
- MeSH terms
- Animals, Anti-Bacterial Agents, Carrier State, Female, Microbial Sensitivity Tests, Phagosomes, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Drug Design, Bacteremia, Immunoconjugates, Intracellular Space, Mice, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.